Cargando…
Effect of deoxyribonuclease I treatment for dementia in end-stage Alzheimer’s disease: a case report
BACKGROUND: Alzheimer's disease is the most common cause of dementia and is characterized by a progressive loss of brain tissue leading to amyloid-β accumulation and severe decline in cognitive function. The cause of Alzheimer’s disease is poorly understood, and available treatments are limited...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884412/ https://www.ncbi.nlm.nih.gov/pubmed/27234814 http://dx.doi.org/10.1186/s13256-016-0931-6 |